Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
P&G Health held an analyst/investor meet, reporting robust FY26 financial performance. Sales grew 16% to Rs.1400cr and Profit After Tax increased 30% to Rs.327cr. Growth was supported by three new product introductions and expanded pharmacy coverage.
Jun 18 2026 21:06:59
Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Procter & Gamble Health held its Investor and Analyst Presentation for FY26, showcasing significant growth with sales up 16% and PAT up 30%. The company also reported a 7% CAGR in net sales and 13% in PAT over the last five years, demonstrating consistent performance.
Jun 18 2026 09:32:16
Procter & Gamble Health Ltd - 500126 - Record Date For Purpose Of Dividend
Procter & Gamble Health fixed August 21, 2026, as the Record Date for its 59th Annual General Meeting. This date will determine eligibility for the dividend, subject to approval at the AGM on August 27, 2026.
May 26 2026 17:46:40
Procter & Gamble Health Ltd - 500126 - Corporate Action-Board approves Dividend
Procter & Gamble Health Board recommended a final dividend of ₹45 per share for FY26. This brings the total dividend for the fiscal year to ₹205 per share. Payout is by September 25, 2026, subject to AGM approval.
May 26 2026 17:33:14
Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
P&G Health reported strong financial performance for Q4 and FY ended March 31, 2026. Q4 sales increased 20% to Rs.365 cr, and profit after tax jumped 55% to Rs.95 cr, driven by strong brand fundamentals. For FY26, sales were up 16% to Rs.1385 cr and PAT grew 30% to Rs.327 cr. The board also recommended a final dividend of Rs.45 per share.
May 26 2026 17:29:53
Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 26, 2026
Procter & Gamble Health board approved audited financial results for FY26, with revenue at ₹1407.97 crore and net profit at ₹326.91 crore. They also recommended a final dividend of ₹45 per equity share, payable by September 25, 2026.
May 26 2026 16:54:45
Read More